Trial Profile
Phase 3 multi-center, double-blind, randomized, parallel group, forced titration study of the efficacy, safety, and tolerability of torcetrapib/atorvastatin compared to fenofibrate in subjects with Fredrickson type IIB dyslipidemia (mixed hyperlipidemia)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2005
Price :
$35
*
At a glance
- Drugs Torcetrapib/atorvastatin (Primary) ; Fenofibrate
- Indications Hyperlipidaemia
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 05 Nov 2005 New trial record.